{"ticker": {"uuid": "4e8d95a3-34a9-4859-a816-2169f7f88cb8", "symbol": "IRON", "name": "Disc Medicine Inc.", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Biotechnology"}, "articles": [{"title": "Going Deeper On Disc Medicine (NASDAQ:IRON)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE13b3RQVzRIQ21odGw2Mk5LVUZEcTlPWU05ZDd3OHNqeFdySDNNTF9IT1B2X1ZSMkI4MDNFUk5ycFppNThBenZvaHlzN0hWSm13S0JSYXJNODhBU1JwMWZwRUsyTFlmVzR4cGlYVHctcjZlbmd0OTQwTWRn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-21T21:57:51+00:00", "published_display": "21 Jul 2026 21:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator With 36.52% Upside Potential", "summary": "Disc Medicine, Inc. (NASDAQ: IRON) is a clinical-stage biopharmaceutical company focused on treating serious hematologic disorders, with a market capitalization of $2.84 billion. The company shows a potential upside of 36.52% based on an average analyst target price of $101.55, d", "url": "https://www.directorstalkinterviews.com/disc-medicine-inc-iron-stock-analysis-biotech-innovator-with-36-52-upside-potential/4121257210", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-21T10:22:00", "published_display": "21 Jul 2026 10:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation", "summary": "Truist Securities has begun coverage of Disc Medicine (IRON) with a positive \"Buy\" rating. This initiation of coverage suggests that Truist analysts see potential for growth or strong performance in the company's stock, influencing investor perception and potentially its stock pr", "url": "http://www.msn.com/en-us/news/other/truist-securities-initiates-coverage-of-disc-medicine-iron-with-buy-recommendation/ar-AA1J2tDB?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-19T21:09:14", "published_display": "19 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 85, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of Disc Medicine, Inc. (NASDAQ: IRON) shareholders. This follows allegations that the company may have issued materially misleading business information, particularly after the FDA issued a Complete Respons", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rosen-a-ranked-and-leading-law-firm-encourages-disc-medicine-inc-1192974", "source_name": "ACCESS Newswire", "published_at": "2026-07-19T19:41:14", "published_display": "19 Jul 2026 19:41", "sentiment": "negative", "sentiment_pct": 25, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(IRON) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an AI-driven analysis of Disc Medicine Inc. (NASDAQ: IRON), highlighting conflicting sentiment across different time horizons and an exceptional 70.0:1 risk-reward setup. It details three distinct institutional trading strategies\u2014Position Trading, Momentum B", "url": "https://news.stocktradersdaily.com/news_release/52/IRON_as_a_Liquidity_Pulse_for_Institutional_Tactics_071926020401_1784484241.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-19T13:41:07", "published_display": "19 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 81, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQTWtRUHBtUE9pSDAxOWFhcjVzWUN2WDV5TkVSbDVuNkk4emtVcW9pckdKRmptRl9FY0MtQU4xa2JJU3FYVzJJV1RqclhxaFBKN2s4ZFVnODBoalJRUGhEa1YwajlCTDRPamNkVjljbndZQlJCVHhNYUhNLUEteXRvSHVxY0ozRHEtVDkya1Y3dW5HdHFuMjM5cDV0Q1ZDUGZHMF9oRUcxa1Nvc1ZQU3VNbXdiQkRiS2E4VGloT1NhRngxRENqX1MxUnhadUJUWF9iUk03elBpb2dXWjlNVERN?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-17T11:46:17+00:00", "published_display": "17 Jul 2026 11:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed", "summary": "DISC MEDICINE (IRON) recently disclosed $50,000 in lobbying expenditures for Q2 2026, focusing on FDA approvals for rare diseases. Insider trading activity for IRON shows significant sales by executives, while institutional investors have both added and decreased their positions.", "url": "https://www.quiverquant.com/news/Lobbying+Update:+$50,000+of+DISC+MEDICINE+lobbying+was+just+disclosed", "source_name": "Quiver Quantitative", "published_at": "2026-07-17T05:20:00", "published_display": "17 Jul 2026 05:20", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing", "summary": "A recent SEC filing revealed that an insider at Disc Medicine sold shares valued at $2,473,780. This transaction could be of interest to investors and analysts tracking insider activity at the company.", "url": "https://www.moomoo.com/news/post/72990737/disc-medicine-insider-sold-shares-worth-2473780-according-to-a", "source_name": "Moomoo", "published_at": "2026-07-16T07:40:56", "published_display": "16 Jul 2026 07:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Investor News: If You Have Suffered Losses in", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter for its bitopertin program, causing the stock price to fall 22%. Investors who purchased Disc Medicine s", "url": "https://www.globenewswire.com/news-release/2026/07/15/3328064/673/en/disc-medicine-investor-news-if-you-have-suffered-losses-in-disc-medicine-inc-nasdaq-iron-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights.html", "source_name": "GlobeNewswire", "published_at": "2026-07-16T07:10:57", "published_display": "16 Jul 2026 07:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts", "summary": "Cantor Fitzgerald reiterated an Overweight rating and $125 price target for Disc Medicine (NASDAQ:IRON), citing upcoming pipeline catalysts. The firm is bullish on bitopertin's Phase 3 study for EPP and X-linked protoporphyria, with data expected in Q4 2026, and also highlighted ", "url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-disc-medicine-stock-rating-on-pipeline-catalysts-93CH-4793370", "source_name": "Investing.com", "published_at": "2026-07-15T12:42:43", "published_display": "15 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine CEO John Quisel sells $2.47m in shares", "summary": "Disc Medicine CEO John Quisel sold approximately $2.47 million worth of shares on July 13, 2026, while simultaneously exercising stock options to acquire shares worth about $352,374. These transactions were executed under a Rule 10b5-1 trading plan. Following these sales and acqu", "url": "https://www.investing.com/news/insider-trading-news/disc-medicine-ceo-john-quisel-sells-247m-in-shares-93CH-4791979", "source_name": "Investing.com", "published_at": "2026-07-15T07:10:57", "published_display": "15 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 14 July By Investing.com", "summary": "This article reports on a Form 4 filing for Disc Medicine Inc. on July 14. The content primarily consists of a brief announcement and various financial market data sections, news links, and promotional material from Investing.com.", "url": "https://ng.investing.com/news/stock-market-news/form-4-disc-medicine-inc-for-14-july-93CH-2599711", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T07:10:57", "published_display": "15 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares", "summary": "Disc Medicine, Inc.'s CEO, John D. Quisel, reported exercising stock options for 33,000 shares and subsequently selling all 33,000 shares in open-market transactions on July 13, 2026. The sales were conducted under a Rule 10b5-1 trading plan adopted on March 12, 2026, with weight", "url": "https://www.stocktitan.net/sec-filings/IRON/form-4-disc-medicine-inc-insider-trading-activity-93a0a25232a3.html", "source_name": "Stock Titan", "published_at": "2026-07-14T06:47:27", "published_display": "14 Jul 2026 06:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Disc Medicine For: 13 July By Investing.com", "summary": "This article from Investing.com announces a Form 144 filing for Disc Medicine, dated July 13. The brief piece includes a stock ticker for IRON and links to comment functionality, providing minimal specific information about the filing itself.", "url": "https://ng.investing.com/news/stock-market-news/form-144-disc-medicine-for-13-july-93CH-2597572", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T21:41:41", "published_display": "13 Jul 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbll5ajBwM3hCc2pUdjlubUZPRXVQSmU3eEpQXzYwZURlQWpJNmd1UWNmZVpmNnJqNzJPUHNRdFFNMVRaYkhad2txeG5ZQ05nSU5UY3g2S1E0Z29meFBza0x3STdBTWpxLVhsUV85WlppZDNjNmRmUHJQdVlWd2ttZFNhN0dHWHBuRlp3TmFCNlFzNlRpb3JMWmd3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:34:58+00:00", "published_display": "13 Jul 2026 20:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Disc Medicine (IRON) H.C. Wainwright 27th Annual Global Investment Conference Summary", "summary": "Disc Medicine presented at the H.C. Wainwright 27th Annual Global Investment Conference, providing an update on its lead asset, bitopertin, for red blood cell disorders. The company plans an NDA filing for bitopertin in October, with a PDUFA date in the second half of next year, ", "url": "https://quartr.com/events/disc-medicine-inc-iron-h-c-wainwright-27th-annual-global-investment-conference_FkMm02AQ", "source_name": "Quartr", "published_at": "2026-07-12T08:11:35", "published_display": "12 Jul 2026 08:11", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) Barclays 27th Annual Global Healthcare Conference Summary", "summary": "Disc Medicine (IRON) presented at the Barclays 27th Annual Global Healthcare Conference, highlighting its strategic focus on severe hematologic disorders with three mid-to-late-stage clinical programs. The company's lead program, bitopertin, for erythropoietic protoporphyria (EPP", "url": "https://quartr.com/events/disc-medicine-iron-barclays-27th-annual-global-healthcare-conference_FkMm0pXw", "source_name": "Quartr", "published_at": "2026-07-12T08:11:35", "published_display": "12 Jul 2026 08:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of investors who suffered losses in Disc Medicine, Inc. (NASDAQ: IRON). The investigation stems from allegations that the company may have issued misleading business information, particularly after the FDA ", "url": "https://www.globenewswire.com/news-release/2026/07/11/3325822/0/en/disc-medicine-investor-news-if-you-have-suffered-losses-in-disc-medicine-inc-nasdaq-iron-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights.html", "source_name": "GlobeNewswire", "published_at": "2026-07-11T15:01:00", "published_display": "11 Jul 2026 15:01", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Disc Medicine, Inc. \u2013 BOATS:IRON", "summary": "This page provides financial information for Disc Medicine, Inc. (IRON) on TradingView, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of access and lists the financial data.", "url": "https://www.tradingview.com/symbols/BOATS-IRON/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T02:39:10", "published_display": "11 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON", "summary": "The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter for its bitopertin program, causing a 22% stock drop. The firm is preparing", "url": "https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302822558.html", "source_name": "PR Newswire", "published_at": "2026-07-10T07:10:03", "published_display": "10 Jul 2026 07:10", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com", "summary": "Disc Medicine's COO, Jonathan Yu, sold 100 shares of company stock for $8,250 on July 7, 2026, after exercising options at a lower price. This transaction was part of a pre-arranged Rule 10b5-1 trading plan. Despite the sale, Yu directly holds 54,324 shares and 23,747 derivative ", "url": "https://ng.investing.com/news/stock-market-news/disc-medicine-coo-jonathan-yu-sells-8250-in-stock-93CH-2594108", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T05:41:59", "published_display": "10 Jul 2026 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 9 July By Investing.com", "summary": "This article reports on a Form 4 filing for Disc Medicine Inc., specifically relating to activity on July 9th. It is a brief administrative notice from Investing.com, providing basic information about the financial filing. The content focuses on the filing itself rather than prov", "url": "https://ng.investing.com/news/stock-market-news/form-4-disc-medicine-inc-for-9-july-93CH-2594110", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T05:41:58", "published_display": "10 Jul 2026 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan", "summary": "Disc Medicine, Inc.'s Chief Operating Officer, Jonathan Yen-Wen Yu, reported exercising stock options for 100 shares at $13.50 each and simultaneously selling 100 shares at an average price of $82.50 on July 7, 2026. These transactions were carried out under a pre-arranged Rule 1", "url": "https://www.stocktitan.net/sec-filings/IRON/form-4-disc-medicine-inc-insider-trading-activity-5577e935df09.html", "source_name": "Stock Titan", "published_at": "2026-07-10T05:11:25", "published_display": "10 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine COO Jonathan Yu sells $8,250 in stock", "summary": "Disc Medicine COO Jonathan Yu sold 100 shares of the company's common stock for $8,250 on July 7, 2026, through a Rule 10b5-1 trading plan. This sale occurred simultaneously with the exercise of stock options to acquire 100 shares at a lower price. Following these transactions, Y", "url": "https://www.investing.com/news/insider-trading-news/disc-medicine-coo-jonathan-yu-sells-8250-in-stock-93CH-4785183", "source_name": "Investing.com", "published_at": "2026-07-09T22:11:25", "published_display": "09 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative", "summary": "Disc Medicine, Inc. has amended its loan agreement with Hercules Capital, securing an immediate US$30 million and extending access to further tranches into 2027 and 2028, with minimum cash covenant testing deferred until mid-2028. This move significantly extends the company's fun", "url": "https://www.sahmcapital.com/news/content/why-disc-medicines-extended-hercules-credit-access-could-reshape-irons-funding-flexibility-narrative-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-09T17:40:09", "published_display": "09 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) COO exercises options and sells 300 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUXJzVmhnc3lVVTVzVDZMa09jbUhNSnBtTXhIZ012TzlKLXdldk40N1A0Wmo3LVc2SHdSN2FzYWdvZm5KS1hHTTZXRV9oNEV3MkpZbEM4Uk9hOS1oOHdFZEFRbTRxemdHMzlLWlZzSDA3WDJxQWowLVZmZHV1TV96ZzNrQ2pfYzlvSlR3d2VpQUl5U3pVNUxaMjg4WVpzdENPY3NiRk50b09xMC1fM0puNg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) COO exercises options, sells 9,700 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOVXRMTEJiYW1SV3pVRWVna281eXlKQS1LU2NqMGdILUFQbm9zVzVBbkIxMWM5U2VIdm1NRG5LN3FKc0t3NXB3Z3hJS29WMnpHN2xRNVh0bTJXaWdfQUloMFp4OWRGZUFUM0hBM1IxTHlFWWJYUGp0MC01SXVNajNqM0JBbjRpeDNlX2d6UGc4dkdQMzgwWHJwMWhhT1loMG55LVlDRFp0c2xaS2Q5ZXdiZQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/disc-medicine-insider-sold-shares-212546365.html", "source_name": "MT Newswires", "published_at": "2026-06-23T21:25:46+00:00", "published_display": "23 Jun 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 23 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQTg1WjJFNkczbHlDVDZUczdRV201N3pSbnJlLTJfTXN0X01INHNkWU5RQ2ttUmJveVRTQmJ0SE1tS1h1RW9qYmhSbUFSU3QzeXNrU2pjR0hFNVRzMS1iNFhXakwxV1E4andyc2prU1lpdnRUM1VCYUh2SllTWUtyNjVLSVZqQUxzMlhrdDBvb19WbE5ZdWtrOVA0dWdJQQ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) legal chief exercises options, sells 7,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOZHRPQi1kUVNzNEdod3Q1YVl6c0d2TVEyb2x4YTlyY1hsM2tEUnFabjYwa19MN3dkMm5YSEpmbGhBV1k4VDBORHV5OTVreC0yQkJnLWlGckxVZ1dFWk15VUJSV2xTaG41VFRCYnE3U0dLVy03bjlqV1hseFB5V1pWZHpueWtQOVlFcDhvSUNpc2EyZHFlVXJOMFI5aEJwRjlOcTA3WS1uTEQzN215dXN5LQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Insider Sold Shares Worth $1,287,801, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/disc-medicine-insider-sold-shares-204808691.html", "source_name": "MT Newswires", "published_at": "2026-06-18T20:48:08+00:00", "published_display": "18 Jun 2026 20:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Iron Mountain Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPb1pwMDZKSUlZVUxnUnhEbEd1STZMYkFXU1AyT0hIRE9aTDRFMmV1VEdvZkhkTnhyRTc0N1o5cVpSUDN3RTVIZWtXQkhmeXVtTC1oSnFLTmh4dHdzVUFkQm9RWjViM2JlTlkxZkJhcElhaC1oT21pOW9PU19xa3NkcTl0UkphUmIxQ1haQVhqR2ZjdWVDczdSQWNuQm45LUpmY2gzbWktUzRBWDg?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-presents-positive-clinical-123000675.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-provides-fda-type-123000380.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:30:00+00:00", "published_display": "09 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-presents-updated-positive-120000898.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T12:00:00+00:00", "published_display": "02 Jun 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Disc Medicine (IRON) Expanding Pre-Approval Access To Bitopertin For Porphyria Patients", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-may-respond-disc-medicine-140716829.html", "source_name": "Simply Wall St.", "published_at": "2026-06-01T14:07:16+00:00", "published_display": "01 Jun 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-launches-expanded-access-123000291.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T12:30:00+00:00", "published_display": "01 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges", "summary": "", "url": "https://finance.yahoo.com/m/5716e68c-ce77-3206-85c8-ad1c2c1d1b9a/disc-medicine-eyes-mid-2026.html", "source_name": "MarketBeat", "published_at": "2026-05-26T04:04:52+00:00", "published_display": "26 May 2026 04:04", "sentiment": "positive", "sentiment_pct": 58, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Morgan Stanley Raises Price Target on Disc Medicine to $80 From $75, Keeps Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-raises-price-target-110118189.html", "source_name": "MT Newswires", "published_at": "2026-05-14T11:01:18+00:00", "published_display": "14 May 2026 11:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look At Disc Medicine (IRON) Valuation After Legal Probes And FDA Complete Response Letter", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOcVZZaFpXbVJubk9MS2pjc2lmTjFUUnJ5VGh4NV9Wd1N2U2I1WlhCLU5fVTVSdkljMTViQm5OYUpiV0l3el9JUndZWVBna2pYTXFuUG5HTG5iUTdsMHI0SHVKX3FZQ0I1NUg5Y2dvMXhUMEJGYnpBNkVCZ3FuYUhTa0E4MngtX25YU2xEbnRqMkRucU5kSnN1dU1QLVpNa2c?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Disc Medicine\u2019s Stock Dips as FDA Approves Pending Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFB3SnVYa29FLVRyTmRvWWpKcVlycTE2ejBDX0xSZV9XZlZyajFXTzdmYVQ1dVZXbW1qel96ZlZHYVZpRmhhYm5JcTlxa2RNYlNaOHB4V1Mwdmg5bUMxMUxtb1JkQV9DSzIxLTY2bm5VWU5zZkNtVFhtSU5n?oc=5", "source_name": "StocksToTrade", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Faces Turmoil Amid FDA Concerns but Investors Not Losing Hope", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE80TVFJZkxadW56blNCZS1BdlN3bUdHWWdOOUk1NTBsTXRGQVZBZTdmTkMyM3RaT1BrNnNEbGNMTEZEVk5wbC1fd1NBcHFyMlIyZWhKZk84bmpVbllMempuM3B5bTIxdjlWRmJUaC01SWd6eEx2dFZWZ1p0cVlnUQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxPeWZaZXAwOTZ5UzBKek1RN2FGanBYM2VZMzFZc0hKRm9RSFZFZDhrUUJzWWNac3Y0bFctdU4wa1g0NTJ0NXU2U0NmQWtSSWFsTmFPNllTWVJ6WlhYQi0xbFlSQmVTU2Z5RmJZYUVKa3o1QUFMZGlkZl9hc2NxQWxQbGZLVDQ5ODlhNWtwemtKdVN3T2dHcFJ6Sk14YXo4WlZPMHB5enU2WE9yZkRJekQ0Mmdfdy1tVWYtdmZ4R1lZQmw5Rm9yMXFuYVpROENKaGpLd2RoclVlc3lTendkdFRKano0TFUwdlZ6MlY3Z0RtU3otRU02NzZJSng4UkdlTm1la0l2RFV0TGxSUjdONThyOVBB?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOcUx0UFdXMXhYT1dCZEhGMVlZWGlqQXFSZkhlY2xSRlh2djdFR0o4QjlvY0RqRzZrUXk4QWVUQmNOU0dxRGNCcGNZbWNTTERKaHNNWGZFbklIRXd1Z2VzX3V6NU9wa0lvUTZ3NnhPcXhOYjAtM19aTGI5amFrWE9rX3dfT0xycFRMQjJibm5YSXRLRUlvUlNZTnFhMmMzX0dyQjg1dGd2Z2xlQlNDbE1CY29Ga1otUklYTzAycVduOA?oc=5", "source_name": "Stock Titan", "published_at": "2024-10-25T07:00:00+00:00", "published_display": "25 Oct 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) Stock Price, News & Analysis $IRON", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5XWmJ4bU45VjR3dzFCMTVmY3R0QUo4bjJvTEZHRU5oYXRqNkxJMnBZejIxckdtUGYtVGRIRnlGWGZ1YndRQmtkUFY4enFhcDJBelppTTdCMGc0dw?oc=5", "source_name": "MarketBeat", "published_at": "2023-01-03T22:33:08+00:00", "published_display": "03 Jan 2023 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Going Deeper On Disc Medicine (NASDAQ:IRON)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTE13b3RQVzRIQ21odGw2Mk5LVUZEcTlPWU05ZDd3OHNqeFdySDNNTF9IT1B2X1ZSMkI4MDNFUk5ycFppNThBenZvaHlzN0hWSm13S0JSYXJNODhBU1JwMWZwRUsyTFlmVzR4cGlYVHctcjZlbmd0OTQwTWRn?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-07-21T21:57:51+00:00", "published_display": "21 Jul 2026 21:57", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator With 36.52% Upside Potential", "summary": "Disc Medicine, Inc. (NASDAQ: IRON) is a clinical-stage biopharmaceutical company focused on treating serious hematologic disorders, with a market capitalization of $2.84 billion. The company shows a potential upside of 36.52% based on an average analyst target price of $101.55, d", "url": "https://www.directorstalkinterviews.com/disc-medicine-inc-iron-stock-analysis-biotech-innovator-with-36-52-upside-potential/4121257210", "source_name": "DirectorsTalk Interviews", "published_at": "2026-07-21T10:22:00", "published_display": "21 Jul 2026 10:22", "sentiment": "positive", "sentiment_pct": 82, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation", "summary": "Truist Securities has begun coverage of Disc Medicine (IRON) with a positive \"Buy\" rating. This initiation of coverage suggests that Truist analysts see potential for growth or strong performance in the company's stock, influencing investor perception and potentially its stock pr", "url": "http://www.msn.com/en-us/news/other/truist-securities-initiates-coverage-of-disc-medicine-iron-with-buy-recommendation/ar-AA1J2tDB?apiversion=v2&domshim=1&noservercache=1&noservertelemetry=1&batchservertelemetry=1&renderwebcomponents=1&wcseo=1", "source_name": "MSN", "published_at": "2026-07-19T21:09:14", "published_display": "19 Jul 2026 21:09", "sentiment": "positive", "sentiment_pct": 85, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of Disc Medicine, Inc. (NASDAQ: IRON) shareholders. This follows allegations that the company may have issued materially misleading business information, particularly after the FDA issued a Complete Respons", "url": "https://www.accessnewswire.com/newsroom/en/business-and-professional-services/rosen-a-ranked-and-leading-law-firm-encourages-disc-medicine-inc-1192974", "source_name": "ACCESS Newswire", "published_at": "2026-07-19T19:41:14", "published_display": "19 Jul 2026 19:41", "sentiment": "negative", "sentiment_pct": 25, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "(IRON) as a Liquidity Pulse for Institutional Tactics", "summary": "This article provides an AI-driven analysis of Disc Medicine Inc. (NASDAQ: IRON), highlighting conflicting sentiment across different time horizons and an exceptional 70.0:1 risk-reward setup. It details three distinct institutional trading strategies\u2014Position Trading, Momentum B", "url": "https://news.stocktradersdaily.com/news_release/52/IRON_as_a_Liquidity_Pulse_for_Institutional_Tactics_071926020401_1784484241.html", "source_name": "Stock Traders Daily", "published_at": "2026-07-19T13:41:07", "published_display": "19 Jul 2026 13:41", "sentiment": "positive", "sentiment_pct": 81, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMi3wFBVV95cUxQTWtRUHBtUE9pSDAxOWFhcjVzWUN2WDV5TkVSbDVuNkk4emtVcW9pckdKRmptRl9FY0MtQU4xa2JJU3FYVzJJV1RqclhxaFBKN2s4ZFVnODBoalJRUGhEa1YwajlCTDRPamNkVjljbndZQlJCVHhNYUhNLUEteXRvSHVxY0ozRHEtVDkya1Y3dW5HdHFuMjM5cDV0Q1ZDUGZHMF9oRUcxa1Nvc1ZQU3VNbXdiQkRiS2E4VGloT1NhRngxRENqX1MxUnhadUJUWF9iUk03elBpb2dXWjlNVERN?oc=5", "source_name": "Stocktwits", "published_at": "2026-07-17T11:46:17+00:00", "published_display": "17 Jul 2026 11:46", "sentiment": "negative", "sentiment_pct": 34, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed", "summary": "DISC MEDICINE (IRON) recently disclosed $50,000 in lobbying expenditures for Q2 2026, focusing on FDA approvals for rare diseases. Insider trading activity for IRON shows significant sales by executives, while institutional investors have both added and decreased their positions.", "url": "https://www.quiverquant.com/news/Lobbying+Update:+$50,000+of+DISC+MEDICINE+lobbying+was+just+disclosed", "source_name": "Quiver Quantitative", "published_at": "2026-07-17T05:20:00", "published_display": "17 Jul 2026 05:20", "sentiment": "negative", "sentiment_pct": 40, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing", "summary": "A recent SEC filing revealed that an insider at Disc Medicine sold shares valued at $2,473,780. This transaction could be of interest to investors and analysts tracking insider activity at the company.", "url": "https://www.moomoo.com/news/post/72990737/disc-medicine-insider-sold-shares-worth-2473780-according-to-a", "source_name": "Moomoo", "published_at": "2026-07-16T07:40:56", "published_display": "16 Jul 2026 07:40", "sentiment": "negative", "sentiment_pct": 30, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Investor News: If You Have Suffered Losses in", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of shareholders of Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter for its bitopertin program, causing the stock price to fall 22%. Investors who purchased Disc Medicine s", "url": "https://www.globenewswire.com/news-release/2026/07/15/3328064/673/en/disc-medicine-investor-news-if-you-have-suffered-losses-in-disc-medicine-inc-nasdaq-iron-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights.html", "source_name": "GlobeNewswire", "published_at": "2026-07-16T07:10:57", "published_display": "16 Jul 2026 07:10", "sentiment": "negative", "sentiment_pct": 28, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts", "summary": "Cantor Fitzgerald reiterated an Overweight rating and $125 price target for Disc Medicine (NASDAQ:IRON), citing upcoming pipeline catalysts. The firm is bullish on bitopertin's Phase 3 study for EPP and X-linked protoporphyria, with data expected in Q4 2026, and also highlighted ", "url": "https://www.investing.com/news/analyst-ratings/cantor-fitzgerald-reiterates-disc-medicine-stock-rating-on-pipeline-catalysts-93CH-4793370", "source_name": "Investing.com", "published_at": "2026-07-15T12:42:43", "published_display": "15 Jul 2026 12:42", "sentiment": "positive", "sentiment_pct": 71, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine CEO John Quisel sells $2.47m in shares", "summary": "Disc Medicine CEO John Quisel sold approximately $2.47 million worth of shares on July 13, 2026, while simultaneously exercising stock options to acquire shares worth about $352,374. These transactions were executed under a Rule 10b5-1 trading plan. Following these sales and acqu", "url": "https://www.investing.com/news/insider-trading-news/disc-medicine-ceo-john-quisel-sells-247m-in-shares-93CH-4791979", "source_name": "Investing.com", "published_at": "2026-07-15T07:10:57", "published_display": "15 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 14 July By Investing.com", "summary": "This article reports on a Form 4 filing for Disc Medicine Inc. on July 14. The content primarily consists of a brief announcement and various financial market data sections, news links, and promotional material from Investing.com.", "url": "https://ng.investing.com/news/stock-market-news/form-4-disc-medicine-inc-for-14-july-93CH-2599711", "source_name": "Investing.com Nigeria", "published_at": "2026-07-15T07:10:57", "published_display": "15 Jul 2026 07:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares", "summary": "Disc Medicine, Inc.'s CEO, John D. Quisel, reported exercising stock options for 33,000 shares and subsequently selling all 33,000 shares in open-market transactions on July 13, 2026. The sales were conducted under a Rule 10b5-1 trading plan adopted on March 12, 2026, with weight", "url": "https://www.stocktitan.net/sec-filings/IRON/form-4-disc-medicine-inc-insider-trading-activity-93a0a25232a3.html", "source_name": "Stock Titan", "published_at": "2026-07-14T06:47:27", "published_display": "14 Jul 2026 06:47", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 144 Disc Medicine For: 13 July By Investing.com", "summary": "This article from Investing.com announces a Form 144 filing for Disc Medicine, dated July 13. The brief piece includes a stock ticker for IRON and links to comment functionality, providing minimal specific information about the filing itself.", "url": "https://ng.investing.com/news/stock-market-news/form-144-disc-medicine-for-13-july-93CH-2597572", "source_name": "Investing.com Nigeria", "published_at": "2026-07-13T21:41:41", "published_display": "13 Jul 2026 21:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise", "summary": "", "url": "https://news.google.com/rss/articles/CBMimgFBVV95cUxNbll5ajBwM3hCc2pUdjlubUZPRXVQSmU3eEpQXzYwZURlQWpJNmd1UWNmZVpmNnJqNzJPUHNRdFFNMVRaYkhad2txeG5ZQ05nSU5UY3g2S1E0Z29meFBza0x3STdBTWpxLVhsUV85WlppZDNjNmRmUHJQdVlWd2ttZFNhN0dHWHBuRlp3TmFCNlFzNlRpb3JMWmd3?oc=5", "source_name": "Stock Titan", "published_at": "2026-07-13T20:34:58+00:00", "published_display": "13 Jul 2026 20:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) H.C. Wainwright 27th Annual Global Investment Conference Summary", "summary": "Disc Medicine presented at the H.C. Wainwright 27th Annual Global Investment Conference, providing an update on its lead asset, bitopertin, for red blood cell disorders. The company plans an NDA filing for bitopertin in October, with a PDUFA date in the second half of next year, ", "url": "https://quartr.com/events/disc-medicine-inc-iron-h-c-wainwright-27th-annual-global-investment-conference_FkMm02AQ", "source_name": "Quartr", "published_at": "2026-07-12T08:11:35", "published_display": "12 Jul 2026 08:11", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) Barclays 27th Annual Global Healthcare Conference Summary", "summary": "Disc Medicine (IRON) presented at the Barclays 27th Annual Global Healthcare Conference, highlighting its strategic focus on severe hematologic disorders with three mid-to-late-stage clinical programs. The company's lead program, bitopertin, for erythropoietic protoporphyria (EPP", "url": "https://quartr.com/events/disc-medicine-iron-barclays-27th-annual-global-healthcare-conference_FkMm0pXw", "source_name": "Quartr", "published_at": "2026-07-12T08:11:35", "published_display": "12 Jul 2026 08:11", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights", "summary": "The Rosen Law Firm is investigating potential securities claims on behalf of investors who suffered losses in Disc Medicine, Inc. (NASDAQ: IRON). The investigation stems from allegations that the company may have issued misleading business information, particularly after the FDA ", "url": "https://www.globenewswire.com/news-release/2026/07/11/3325822/0/en/disc-medicine-investor-news-if-you-have-suffered-losses-in-disc-medicine-inc-nasdaq-iron-you-are-encouraged-to-contact-the-rosen-law-firm-about-your-rights.html", "source_name": "GlobeNewswire", "published_at": "2026-07-11T15:01:00", "published_display": "11 Jul 2026 15:01", "sentiment": "negative", "sentiment_pct": 19, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Price to earnings forward of Disc Medicine, Inc. \u2013 BOATS:IRON", "summary": "This page provides financial information for Disc Medicine, Inc. (IRON) on TradingView, specifically focusing on its forward price-to-earnings ratio. It indicates that the market was closed at the time of access and lists the financial data.", "url": "https://www.tradingview.com/symbols/BOATS-IRON/financials-statistics-and-ratios/price-earnings-fwd/", "source_name": "TradingView", "published_at": "2026-07-11T02:39:10", "published_display": "11 Jul 2026 02:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON", "summary": "The Rosen Law Firm is investigating potential securities claims against Disc Medicine, Inc. (NASDAQ: IRON) after the FDA issued a Complete Response Letter for its bitopertin program, causing a 22% stock drop. The firm is preparing", "url": "https://www.prnewswire.com/news-releases/rosen-law-firm-encourages-disc-medicine-inc-investors-to-inquire-about-securities-class-action-investigation--iron-302822558.html", "source_name": "PR Newswire", "published_at": "2026-07-10T07:10:03", "published_display": "10 Jul 2026 07:10", "sentiment": "negative", "sentiment_pct": 20, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 77, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com", "summary": "Disc Medicine's COO, Jonathan Yu, sold 100 shares of company stock for $8,250 on July 7, 2026, after exercising options at a lower price. This transaction was part of a pre-arranged Rule 10b5-1 trading plan. Despite the sale, Yu directly holds 54,324 shares and 23,747 derivative ", "url": "https://ng.investing.com/news/stock-market-news/disc-medicine-coo-jonathan-yu-sells-8250-in-stock-93CH-2594108", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T05:41:59", "published_display": "10 Jul 2026 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 9 July By Investing.com", "summary": "This article reports on a Form 4 filing for Disc Medicine Inc., specifically relating to activity on July 9th. It is a brief administrative notice from Investing.com, providing basic information about the financial filing. The content focuses on the filing itself rather than prov", "url": "https://ng.investing.com/news/stock-market-news/form-4-disc-medicine-inc-for-9-july-93CH-2594110", "source_name": "Investing.com Nigeria", "published_at": "2026-07-10T05:41:58", "published_display": "10 Jul 2026 05:41", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan", "summary": "Disc Medicine, Inc.'s Chief Operating Officer, Jonathan Yen-Wen Yu, reported exercising stock options for 100 shares at $13.50 each and simultaneously selling 100 shares at an average price of $82.50 on July 7, 2026. These transactions were carried out under a pre-arranged Rule 1", "url": "https://www.stocktitan.net/sec-filings/IRON/form-4-disc-medicine-inc-insider-trading-activity-5577e935df09.html", "source_name": "Stock Titan", "published_at": "2026-07-10T05:11:25", "published_display": "10 Jul 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine COO Jonathan Yu sells $8,250 in stock", "summary": "Disc Medicine COO Jonathan Yu sold 100 shares of the company's common stock for $8,250 on July 7, 2026, through a Rule 10b5-1 trading plan. This sale occurred simultaneously with the exercise of stock options to acquire 100 shares at a lower price. Following these transactions, Y", "url": "https://www.investing.com/news/insider-trading-news/disc-medicine-coo-jonathan-yu-sells-8250-in-stock-93CH-4785183", "source_name": "Investing.com", "published_at": "2026-07-09T22:11:25", "published_display": "09 Jul 2026 22:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative", "summary": "Disc Medicine, Inc. has amended its loan agreement with Hercules Capital, securing an immediate US$30 million and extending access to further tranches into 2027 and 2028, with minimum cash covenant testing deferred until mid-2028. This move significantly extends the company's fun", "url": "https://www.sahmcapital.com/news/content/why-disc-medicines-extended-hercules-credit-access-could-reshape-irons-funding-flexibility-narrative-2026-07-09", "source_name": "Sahm", "published_at": "2026-07-09T17:40:09", "published_display": "09 Jul 2026 17:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) COO exercises options and sells 300 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxNUXJzVmhnc3lVVTVzVDZMa09jbUhNSnBtTXhIZ012TzlKLXdldk40N1A0Wmo3LVc2SHdSN2FzYWdvZm5KS1hHTTZXRV9oNEV3MkpZbEM4Uk9hOS1oOHdFZEFRbTRxemdHMzlLWlZzSDA3WDJxQWowLVZmZHV1TV96ZzNrQ2pfYzlvSlR3d2VpQUl5U3pVNUxaMjg4WVpzdENPY3NiRk50b09xMC1fM0puNg?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-30T07:00:00+00:00", "published_display": "30 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) COO exercises options, sells 9,700 shares under 10b5-1 plan", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOVXRMTEJiYW1SV3pVRWVna281eXlKQS1LU2NqMGdILUFQbm9zVzVBbkIxMWM5U2VIdm1NRG5LN3FKc0t3NXB3Z3hJS29WMnpHN2xRNVh0bTJXaWdfQUloMFp4OWRGZUFUM0hBM1IxTHlFWWJYUGp0MC01SXVNajNqM0JBbjRpeDNlX2d6UGc4dkdQMzgwWHJwMWhhT1loMG55LVlDRFp0c2xaS2Q5ZXdiZQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-24T07:00:00+00:00", "published_display": "24 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Insider Sold Shares Worth $2,387,296, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/disc-medicine-insider-sold-shares-212546365.html", "source_name": "MT Newswires", "published_at": "2026-06-23T21:25:46+00:00", "published_display": "23 Jun 2026 21:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Form 4 Disc Medicine Inc For: 23 June By Investing.com", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxOQTg1WjJFNkczbHlDVDZUczdRV201N3pSbnJlLTJfTXN0X01INHNkWU5RQ2ttUmJveVRTQmJ0SE1tS1h1RW9qYmhSbUFSU3QzeXNrU2pjR0hFNVRzMS1iNFhXakwxV1E4andyc2prU1lpdnRUM1VCYUh2SllTWUtyNjVLSVZqQUxzMlhrdDBvb19WbE5ZdWtrOVA0dWdJQQ?oc=5", "source_name": "Investing.com Canada", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (NASDAQ: IRON) legal chief exercises options, sells 7,500 shares", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxOZHRPQi1kUVNzNEdod3Q1YVl6c0d2TVEyb2x4YTlyY1hsM2tEUnFabjYwa19MN3dkMm5YSEpmbGhBV1k4VDBORHV5OTVreC0yQkJnLWlGckxVZ1dFWk15VUJSV2xTaG41VFRCYnE3U0dLVy03bjlqV1hseFB5V1pWZHpueWtQOVlFcDhvSUNpc2EyZHFlVXJOMFI5aEJwRjlOcTA3WS1uTEQzN215dXN5LQ?oc=5", "source_name": "Stock Titan", "published_at": "2026-06-23T07:00:00+00:00", "published_display": "23 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Insider Sold Shares Worth $1,287,801, According to a Recent SEC Filing", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/disc-medicine-insider-sold-shares-204808691.html", "source_name": "MT Newswires", "published_at": "2026-06-18T20:48:08+00:00", "published_display": "18 Jun 2026 20:48", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Is Iron Mountain Stock Underperforming the Nasdaq?", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqwFBVV95cUxPb1pwMDZKSUlZVUxnUnhEbEd1STZMYkFXU1AyT0hIRE9aTDRFMmV1VEdvZkhkTnhyRTc0N1o5cVpSUDN3RTVIZWtXQkhmeXVtTC1oSnFLTmh4dHdzVUFkQm9RWjViM2JlTlkxZkJhcElhaC1oT21pOW9PU19xa3NkcTl0UkphUmIxQ1haQVhqR2ZjdWVDczdSQWNuQm45LUpmY2gzbWktUzRBWDg?oc=5", "source_name": "Market source", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-presents-positive-clinical-123000675.html", "source_name": "GlobeNewswire", "published_at": "2026-06-12T12:30:00+00:00", "published_display": "12 Jun 2026 12:30", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-provides-fda-type-123000380.html", "source_name": "GlobeNewswire", "published_at": "2026-06-09T12:30:00+00:00", "published_display": "09 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Updated Positive Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-presents-updated-positive-120000898.html", "source_name": "GlobeNewswire", "published_at": "2026-06-02T12:00:00+00:00", "published_display": "02 Jun 2026 12:00", "sentiment": "positive", "sentiment_pct": 58, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "How Investors May Respond To Disc Medicine (IRON) Expanding Pre-Approval Access To Bitopertin For Porphyria Patients", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/investors-may-respond-disc-medicine-140716829.html", "source_name": "Simply Wall St.", "published_at": "2026-06-01T14:07:16+00:00", "published_display": "01 Jun 2026 14:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/disc-medicine-launches-expanded-access-123000291.html", "source_name": "GlobeNewswire", "published_at": "2026-06-01T12:30:00+00:00", "published_display": "01 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Eyes Mid-2026 Bitopertin Approval as EPP Trial Demand Surges", "summary": "", "url": "https://finance.yahoo.com/m/5716e68c-ce77-3206-85c8-ad1c2c1d1b9a/disc-medicine-eyes-mid-2026.html", "source_name": "MarketBeat", "published_at": "2026-05-26T04:04:52+00:00", "published_display": "26 May 2026 04:04", "sentiment": "positive", "sentiment_pct": 58, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Morgan Stanley Raises Price Target on Disc Medicine to $80 From $75, Keeps Overweight Rating", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/morgan-stanley-raises-price-target-110118189.html", "source_name": "MT Newswires", "published_at": "2026-05-14T11:01:18+00:00", "published_display": "14 May 2026 11:01", "sentiment": "positive", "sentiment_pct": 66, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 85, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "A Look At Disc Medicine (IRON) Valuation After Legal Probes And FDA Complete Response Letter", "summary": "", "url": "https://news.google.com/rss/articles/CBMinwFBVV95cUxOcVZZaFpXbVJubk9MS2pjc2lmTjFUUnJ5VGh4NV9Wd1N2U2I1WlhCLU5fVTVSdkljMTViQm5OYUpiV0l3el9JUndZWVBna2pYTXFuUG5HTG5iUTdsMHI0SHVKX3FZQ0I1NUg5Y2dvMXhUMEJGYnpBNkVCZ3FuYUhTa0E4MngtX25YU2xEbnRqMkRucU5kSnN1dU1QLVpNa2c?oc=5", "source_name": "Market source", "published_at": "2026-05-06T07:00:00+00:00", "published_display": "06 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine\u2019s Stock Dips as FDA Approves Pending Concerns", "summary": "", "url": "https://news.google.com/rss/articles/CBMiekFVX3lxTFB3SnVYa29FLVRyTmRvWWpKcVlycTE2ejBDX0xSZV9XZlZyajFXTzdmYVQ1dVZXbW1qel96ZlZHYVZpRmhhYm5JcTlxa2RNYlNaOHB4V1Mwdmg5bUMxMUxtb1JkQV9DSzIxLTY2bm5VWU5zZkNtVFhtSU5n?oc=5", "source_name": "StocksToTrade", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Faces Turmoil Amid FDA Concerns but Investors Not Losing Hope", "summary": "", "url": "https://news.google.com/rss/articles/CBMifkFVX3lxTE80TVFJZkxadW56blNCZS1BdlN3bUdHWWdOOUk1NTBsTXRGQVZBZTdmTkMyM3RaT1BrNnNEbGNMTEZEVk5wbC1fd1NBcHFyMlIyZWhKZk84bmpVbllMempuM3B5bTIxdjlWRmJUaC01SWd6eEx2dFZWZ1p0cVlnUQ?oc=5", "source_name": "timothysykes.com", "published_at": "2026-02-17T08:00:00+00:00", "published_display": "17 Feb 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Announces Pricing of $225.5 Million Upsized Public Offering of Common Stock and Pre-Funded Warrants", "summary": "", "url": "https://news.google.com/rss/articles/CBMikgJBVV95cUxPeWZaZXAwOTZ5UzBKek1RN2FGanBYM2VZMzFZc0hKRm9RSFZFZDhrUUJzWWNac3Y0bFctdU4wa1g0NTJ0NXU2U0NmQWtSSWFsTmFPNllTWVJ6WlhYQi0xbFlSQmVTU2Z5RmJZYUVKa3o1QUFMZGlkZl9hc2NxQWxQbGZLVDQ5ODlhNWtwemtKdVN3T2dHcFJ6Sk14YXo4WlZPMHB5enU2WE9yZkRJekQ0Mmdfdy1tVWYtdmZ4R1lZQmw5Rm9yMXFuYVpROENKaGpLd2RoclVlc3lTendkdFRKano0TFUwdlZ6MlY3Z0RtU3otRU02NzZJSng4UkdlTm1la0l2RFV0TGxSUjdONThyOVBB?oc=5", "source_name": "GlobeNewswire", "published_at": "2025-01-22T08:00:00+00:00", "published_display": "22 Jan 2025 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine Presents Positive Data from SAD Cohorts of a Phase 1b Trial in Patients with Chronic Kidney Disease (CKD) and Anemia at the 2024 American Society of Nephrology (ASN) Kidney Week", "summary": "", "url": "https://news.google.com/rss/articles/CBMivwFBVV95cUxOcUx0UFdXMXhYT1dCZEhGMVlZWGlqQXFSZkhlY2xSRlh2djdFR0o4QjlvY0RqRzZrUXk4QWVUQmNOU0dxRGNCcGNZbWNTTERKaHNNWGZFbklIRXd1Z2VzX3V6NU9wa0lvUTZ3NnhPcXhOYjAtM19aTGI5amFrWE9rX3dfT0xycFRMQjJibm5YSXRLRUlvUlNZTnFhMmMzX0dyQjg1dGd2Z2xlQlNDbE1CY29Ga1otUklYTzAycVduOA?oc=5", "source_name": "Stock Titan", "published_at": "2024-10-25T07:00:00+00:00", "published_display": "25 Oct 2024 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Disc Medicine (IRON) Stock Price, News & Analysis $IRON", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5XWmJ4bU45VjR3dzFCMTVmY3R0QUo4bjJvTEZHRU5oYXRqNkxJMnBZejIxckdtUGYtVGRIRnlGWGZ1YndRQmtkUFY4enFhcDJBelppTTdCMGc0dw?oc=5", "source_name": "MarketBeat", "published_at": "2023-01-03T22:33:08+00:00", "published_display": "03 Jan 2023 22:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxNYmZ3aHMyMjBuNmlEUGN6NWZBZV85cEFWNndJaVNoNEVYNk84MlNKRXJ0RXpRQl9wN1RsekhxM3loY1RRNDJhTnVremtReHhLQWVHS053VzRBUTduSkdqRGt1YkxMMThqZHoydElPX1Zfd3hEMi15VlRwRGRvZ2JqRDFneVVxN0JCYzQ4QlV5TTBEOWx3?oc=5", "source_name": "Market source", "published_at": "2026-07-16T18:49:22+00:00", "published_display": "16 Jul 2026 18:49", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMinAFBVV95cUxOZExLRk1BSFNPMnpMdEFEWjNtbWlkZUQ1aHJHZEtMZHJHZWZDZUI0ck1FM2JqWG9ncDRSNGxEWHZLemZualBEY3BVVzdiUmZiVmxqMFdnbEczbEpvTFBscnA3YVVMWmQ3TkFsVjBDZzl6VEZQanh1UkRaS2hiRTNPbGFwajRSV1A1amFKcnFhcFVITHdydjJpblVRTWI?oc=5", "source_name": "Market source", "published_at": "2026-07-13T07:00:00+00:00", "published_display": "13 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "There May Be Reason For Hope In Puma Biotechnology's (NASDAQ:PBYI) Disappointing Earnings", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-15T07:00:00+00:00", "published_display": "15 May 2026 07:00", "sentiment": "negative", "sentiment_pct": 34, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology's (NASDAQ:PBYI) Conservative Accounting Might Explain Soft Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxNZXcyN1VKc0J0RTFtSER6TGRSZm8xSWs2c0paem5paDd3V0J1cjF6ajhFb29tRFpUWWpxYUhzZjFkSXhYQ0lBNTVlbTdCRERpSXNjaGpDajFPOVlpRS1qV2xHMTRHS2pjVVBZMWFfNzItWE9FeENtQ2duMUxVQm5kOG41eVlrNUpObXp2VlhfekdhMVh2X0hjN3ZFZThZNUdWakFLUXJ4aFBVN2JyR2c?oc=5", "source_name": "Market source", "published_at": "2026-05-14T07:00:00+00:00", "published_display": "14 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Puma Biotechnology, Inc. (NASDAQ:PBYI) Analysts Are Pretty Bullish On The Stock After Recent Results", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Earnings Update: Here's Why Analysts Just Lifted Their Puma Biotechnology, Inc. (NASDAQ:PBYI) Price Target To US$5.00", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxPSUN3RjZYMEJ2VUdKQjJpRkZaUXRzM2NTa05WWmlmWHJnZDlJeUpTdFM5Wmk0SUhjclU2dldTZFIyRmZZeGJSNGM2SUNiSGJSYjh1VjYyR0hPZ2FJbWdsbHExYlhwMW1HRTZ0NUxwQzU1b2g4MGpwSHdoMkdIOUtqOXBBYk92LVk2cEFZMzVISjB3c04ydVBEYWw2cVVsdw?oc=5", "source_name": "Market source", "published_at": "2026-05-11T07:00:00+00:00", "published_display": "11 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Regeneron (NASDAQ:REGN) Vs The Rest Of The Biotechnology Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMirAFBVV95cUxNWW9GYm5uRzlBX2ZiZXA3RkdDXzJhaFd2N1ZwR21jaXhiRkZQSTNHT0hMaUFjSGl6VXZfOURKemF2bWlFS1hKTXBjZUw4amdVQ0I4QlVnNmFkY1VTQ25pUjBiZGNDUE9QdWdOZHAxV1I1ejN6UE9WdGpseUdrMVA5MXBXWXJmWDBkZUdWUkxpOURCdlZlbDlQR3M5cjAzaDFtakFNblRTa3c0Q1J6?oc=5", "source_name": "Market source", "published_at": "2026-04-25T07:00:00+00:00", "published_display": "25 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Biotechnology Stocks Q3 Results: Benchmarking Natera (NASDAQ:NTRA)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxPZzZDSEhwNlVYQU9kNXBMMU5ia0FTU0RxRlYwb0I1RERNODN4N0VwRFZWMUY4ODh3eWNkTkp0UERreFlSTllocGk4a2ZKcGlJVjQ4d1dXWlNnYTc5UlNMZm4wc2xITjRQVzhRb3Z5LXllQmhvUHNIaXB3LXk1RUw1WnRPam9wcVE1MXFxSmVzVF9MVmRyMWIwdVkxS1N3MUJZUzByLWxrVDlSSUk4QnNsXzJYbw?oc=5", "source_name": "Market source", "published_at": "2026-04-21T07:00:00+00:00", "published_display": "21 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Biotechnology Stocks\u2019 Q4 Earnings: Incyte (NASDAQ:INCY) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMi5gFBVV95cUxNWEtsYkktQkxQRHpTMHJOZzJaN09fT3R5aUpjZ0xEQTZXZGlCVUk0alZrVXhIRERNOW9feVJ1X0R4VUI2Q0FjUGIwTWpIRXE2dXpCLW9NdVdoSEE5b0JEM18wN2FQSGdXMDZfOGJ3STJPUmQ2VVBIbUQ5djhTZ01RTmpxLTdKRmdhN0U3RE52N0dEUzh4VFZ5c3dDd0ppZ1VYeGc0Mm5oQlU5TGJlQldpVHpoVjlhdXZ6ek0yaTBuQV9UUjNFT19kWFZ4QVViODkwN2ppOFRQU3lHQ1IxdXhrRkFGS3E0QQ?oc=5", "source_name": "TradingView", "published_at": "2026-03-29T07:00:00+00:00", "published_display": "29 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 105, "total_relevant": 54, "sentiment_summary": {"positive": 12, "negative": 8, "neutral": 34, "score": 51, "total": 54, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 82, "events": [{"event": "general", "label": "Market update", "weight": 18.5, "count": 33}, {"event": "earnings", "label": "Earnings", "weight": 4.26, "count": 10}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 2.75, "count": 5}, {"event": "analyst", "label": "Analyst action", "weight": 2.2, "count": 4}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.1, "count": 2}], "positive_events": 12, "negative_events": 8}, "market_context": {"has_market_context": true, "latest_close": 76.15, "latest_week": "2026-07-17", "one_week_move": -0.6, "four_week_move": 7.6, "twelve_week_move": 10.6, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": 1.432323, "market_dynamics_buy_signal": false, "relative_strength": -4.233546, "fair_value_gap": 31.0, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "positive", "expectation_probability": 55.5778, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-0.6% over one week, +7.6% over four weeks, trend inactive, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 50, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 8}, {"label": "GlobeNewswire", "count": 7}, {"label": "Stock Titan", "count": 7}, {"label": "Investing.com Nigeria", "count": 4}, {"label": "Investing.com", "count": 3}, {"label": "MT Newswires", "count": 3}, {"label": "Quartr", "count": 2}, {"label": "TradingView", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 45}, {"label": "Industry context", "count": 9}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 33}, {"label": "Earnings", "count": 10}, {"label": "Regulatory and legal", "count": 5}, {"label": "Analyst action", "count": 4}, {"label": "Balance sheet", "count": 2}]}, "insights": [{"label": "Weighted tone", "value": "51/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "82/100 classification confidence."}, {"label": "Company focus", "value": "45", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "1", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-0.6% over one week, +7.6% over four weeks, trend inactive, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Going Deeper On Disc Medicine (NASDAQ:IRON)"}], "updated_at": "2026-07-22T11:44:18.257914+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}